Amgen acquires stake in BeiGene to grow cancer drug business to China

Amgen acquires stake in BeiGene to grow cancer drug business to China

Amgen acquires stake in BeiGene to expand cancer drug business to China

By ADAM FEUERSTEIN

RUBY WALLAU FOR STAT

For BeiGene, the partnership bolsters its existing commercial operations in China, which already sells certain cancer medicines owned by Celgene.

READ MORE